Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy. 2009

Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, the Netherlands. o.vrieze@nki.nl

OBJECTIVE To examine the effect of adjuvant radiotherapy on regional control of melanoma neck node metastasis. METHODS A single-institution retrospective study. METHODS Tertiary care cancer center. METHODS The study included 64 patients with melanoma neck node metastasis who were treated with neck dissection between 1989 and 2004 in The Netherlands Cancer Institute, Amsterdam. Twenty-four patients were treated with surgery only (15 modified radical neck dissections [MRNDs] and 9 selective neck dissections [SNDs]) (S group), and 40 patients underwent surgery (28 MRNDs and 12 SNDs) and adjuvant radiotherapy (S+RT group). RESULTS Prognostic factors, ie, number of nodes, size of nodes, and extracapsular extension, were worse in the S+RT group. With a median follow-up of 2.5 years, the 2-year ipsilateral regional recurrence (RR) rate was 18% in the S+RT group and 46% in the S group. This 28% difference in RR was not statistically significant (P = .16). However, evaluation of the effect of adjuvant RT in multivariate analysis revealed a significant reduction of the RR rate after correction for the number of involved nodes (P = .04). In the S group, SND was associated with a trend toward worse RR rate compared with MRND but was not statistically significant in univariate analysis (P = .08). The type of neck dissection did not influence the RR rate in the S+RT group (P = .60). Three of the 4 RRs occurred outside the dissected volume after SND in the S group. CONCLUSIONS Based on our findings, we conclude that, compared with extended neck dissection, SND leads to inferior regional control in patients with melanoma neck node metastasis who are not treated with RT, even those with low-risk neck disease. Furthermore, our results suggest that adjuvant RT improves regional control in patients with 2 or more involved nodes.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
November 2014, JAMA otolaryngology-- head & neck surgery,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
January 2023, Clinical oncology (Royal College of Radiologists (Great Britain)),
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
January 2023, Journal of surgical oncology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
January 2014, American journal of otolaryngology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
March 2019, Oral oncology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
April 2013, Auris, nasus, larynx,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
September 2000, Annals of surgical oncology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
September 2000, Annals of surgical oncology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
February 2022, Annals of surgical oncology,
Olga Hamming-Vrieze, and Alfons J M Balm, and Wilma D Heemsbergen, and Thijs Hooft van Huysduynen, and Coen R N Rasch
October 1997, Head & neck,
Copied contents to your clipboard!